tiprankstipranks
Cara Therapeutics (CARA)
NASDAQ:CARA
US Market

Cara Therapeutics (CARA) Stock Forecast & Price Target

Compare
2,284 Followers
See the Price Targets and Ratings of:

CARA Financial Forecast

CARA Earnings Forecast

The previous quarter’s earnings for CARA were -$0.23.
The previous quarter’s earnings for CARA were -$0.23.

CARA Sales Forecast

The previous quarter’s earnings for CARA were $2.56M.
The previous quarter’s earnings for CARA were $2.56M.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity
$120$12
Hold
133.01%
Upside
Downgraded
06/12/24
Cara Therapeutics downgraded to Hold from Buy at CanaccordCara Therapeutics downgraded to Hold from Buy at Canaccord
Piper Sandler
$12
Hold
133.01%
Upside
Reiterated
05/14/24
Piper Sandler Sticks to Their Hold Rating for Cara Therapeutics (CARA)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cara Therapeutics

Currently, no data available
Please return soon. This page is being updated.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CARA Analyst Recommendation Trends

Rating
Apr 24
May 24
Jun 24
Aug 24
Dec 24
Strong Buy
7
10
7
5
0
Buy
0
0
0
0
0
Hold
0
1
5
6
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
11
12
11
7
In the current month, CARA has received 0 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. CARA average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

CARA Stock Forecast FAQ

What is CARA’s average 12-month price target, according to analysts?
Currently, no data Available
What is CARA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CARA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is CARA a Buy, Sell or Hold?
      Currently, no data Available
      What is Cara Therapeutics’s price target?
      Currently, no data Available
      What do analysts say about Cara Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of CARA?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis